ACAD - CIK 0001070494
ACADIA PHARMACEUTICALS INC has filed 1,357 documents with the SEC between 2000 and 2026. The most frequent type is insider trade (615 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2025-06-02 | 2025-05-29 |
| Insider trade | 4 | 2025-06-02 | 2025-05-29 |
| Insider trade | 4 | 2025-06-02 | 2025-05-29 |
| Insider trade | 4 | 2025-06-02 | 2025-05-29 |
| Insider trade | 4 | 2025-06-02 | 2025-05-29 |
| Major company event | 8-K | 2025-05-29 | 2025-05-29 |
| EFFECT | - | 2025-05-23 | - |
| Company correspondence | CORRESP | 2025-05-21 | - |
| Major company event | 8-K | 2025-05-20 | 2025-05-15 |
| Insider trade | 4 | 2025-05-19 | 2025-05-16 |
| Insider trade | 4 | 2025-05-19 | 2025-05-16 |
| Insider sale notice | 144 | 2025-05-16 | - |
| Insider sale notice | 144 | 2025-05-16 | - |
| SEC correspondence | UPLOAD | 2025-05-14 | - |
| Securities registration | S-3 | 2025-05-09 | - |
| Quarterly report | 10-Q | 2025-05-08 | 2025-03-31 |
| Major company event | 8-K | 2025-05-07 | 2025-05-07 |
| Insider trade | 4 | 2025-05-02 | 2025-05-01 |
| Insider trade | 4 | 2025-05-02 | 2025-05-01 |
| Annual report to shareholders | ARS | 2025-04-25 | 2024-12-31 |
| Proxy statement | DEF 14A | 2025-04-25 | 2025-05-29 |
| Major company event | 8-K | 2025-04-16 | 2025-04-15 |
| Insider trade | 4 | 2025-04-08 | 2025-04-05 |
| Insider trade | 4 | 2025-04-08 | 2025-04-05 |
| Insider trade | 4 | 2025-03-26 | 2025-03-24 |
| Insider trade | 4 | 2025-03-26 | 2025-03-24 |
| Insider trade | 4 | 2025-03-26 | 2025-03-24 |
| Insider trade | 4 | 2025-03-26 | 2025-03-24 |
| Insider trade | 4 | 2025-03-26 | 2025-03-24 |
| Insider sale notice | 144 | 2025-03-06 | - |
| Insider trade | 4 | 2025-03-06 | 2025-03-05 |
| Annual report | 10-K | 2025-02-27 | 2024-12-31 |
| Major company event | 8-K | 2025-02-26 | 2025-02-26 |
| Insider trade | 4 | 2025-02-25 | 2025-02-23 |
| Insider trade | 4 | 2025-02-25 | 2025-02-23 |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-07 | - |
| Major company event | 8-K | 2024-12-11 | 2024-12-11 |
| Insider trade | 4 | 2024-12-10 | 2024-12-09 |
| New insider ownership | 3 | 2024-12-10 | 2024-12-09 |
| Major company event | 8-K | 2024-11-20 | 2024-11-18 |
| Insider trade | 4 | 2024-11-19 | 2024-11-17 |
| Insider trade | 4 | 2024-11-19 | 2024-11-17 |
| Insider trade | 4 | 2024-11-19 | 2024-11-17 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Quarterly report | 10-Q | 2024-11-07 | 2024-09-30 |
| Major company event | 8-K | 2024-11-06 | 2024-11-06 |
| Insider trade | 4 | 2024-10-15 | 2024-10-12 |
| Insider trade | 4 | 2024-09-25 | 2024-09-23 |
| New insider ownership | 3 | 2024-09-25 | 2024-09-23 |